Available evidence showed that ADAM17 expression was elevated in the myocardium of patients with dilated cardiomyopathy (Fedak et al., 2006) and ADAM17 gene silencing prevented Ang II-induced cardiac hypertrophy and fibrosis in mice (Wang et al., 2009). This evidence concerns the gene ADAM17 and cardiac hypertrophy.